BPGbio, Inc. will present its novel approach to targeted protein degradation at the US Pharma Partnering Summit, highlighting advancements in its E2-based therapeutics aimed at treating conditions like Huntington’s and Alzheimer’s diseases, as well as potential oncology indications.
Company Information
Company
BPGbio
Location
Waltham, Massachusetts, United States
About
BPGbio is a clinical-stage biopharma reimagining how patient biology can be modeled using unbiased AI algorithms, to accelerate and de-risk the process of drug discovery for humanity. Our Interrogative Biology® platform has produced and guided development of more than a dozen therapeutics and diagnostics candidates in the areas of oncology, neurology and rare diseases, including several in advanced clinical stages. As BPGbio continues to expand our biobank, and the network insights that are derived from it, we anticipate more promising discoveries made with improved time and cost efficiency.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BPGbio ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
WalthamBiotechnologyHealth CareArtificial IntelligenceTherapeuticsMachine Learning